• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Cord colitis syndrome found to have a novel infectious etiology

bys25qthea
August 8, 2013
in Chronic Disease, Infectious Disease, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. The genome of a novel bacterium Bradyrhizobium enterica was discovered via gene sequencing in patients with cord colitis. 

2. The association of this bacterium with cord colitis suggests it may be an opportunistic pathogen of humans. 

Study Rundown:  Hematopoietic stem-cell transplantation (HSCT) is a modern procedure used to treat various hematologic and oncologic diseases by repopulating a patient’s immune system by using the cells of a donor.  HSCT requires complete suppression and even destruction of the host’s immune system and therefore may cause many adverse events including graft versus host disease (GVHD) and unusual opportunistic infections.  Colitis is a common adverse effect of HSCT and is thought to stem from various etiologies including bacterial, viral and parasitic infections, as well as GVHD.  Cord colitis is a syndrome specific to patients who have undergone umbilical-cord HSCT and is histopathologically distinct from other forms of colitis.  Additionally, conventional infectious work ups fail to reveal a known infectious pathogen in this disease. 

The authors of this study found that treating cord colitis patients with antibiotics resulted in the resolution of symptoms.  They then performed a sequencing study that identified what appears to be an opportunistic pathogen as the etiology of the disease.  The fact that B. enterica was found in the cord colitis patients and in no controls would suggest it is associated with the syndrome.  However, the overall number of patients with cord colitis who were tested was very small and from a single center.  Additionally, while not a requirement to prove disease causation, the organism was never cultured by the authors.  Demonstrating a change in DNA copy numbers after antibiotic treatment might help fulfill the modern adaptation of Koch’s postulates.  Taken together the results display an impressive demonstration of modern gene sequencing to identify a novel bacterial genome that might be an opportunistic human pathogen.

Click to read the study, published today in NEJM

Background Reading: A reconsideration of Koch’s Postulates

RELATED REPORTS

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

Early-life body size not an independent risk factor for colorectal cancer

Characterization of prognostic markers of residual neoplastic disease following hysterectomy

In-Depth [genome sequencing case control study]: The authors of this study selected patients from Brigham and Women’s Hospital who had developed cord colitis after receiving an umbilical cord hematopoietic stem-cell transplant.  Using archived, paraffin-embedded colon biopsy specimens, they performed mass DNA sequencing and subtracted known human and microbial sequences.  The remaining sequences were assembled into a draft genome that was homologous to known bacteria of the bradyrhizobium genus and subsequently dubbed Bradyrhizobium enterica.  They then used polymerase chain reaction (PCR) to identify this genome in 3 additional patients with cord colitis, but found it was not present in patients selected as controls.

By Akira Shishido, MD and Mitalee Patil

More from this author: Pneumocystis linked to sudden infant deaths, Continuous infusion of beta-lactams may be superior to bolus therapy, Novel antiviral drug reduces influenza viral load, Three months of antibiotics appear to effectively treat early-onset spinal implant infections 

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: Bradyrhizobium entericacord colitisgraft versus hostGVFDHematopoietic stem-cell transplantationHSCToncology
Previous Post

High glucose levels associated with increased risk of dementia

Next Post

Probiotic formulations do not prevent antibiotic-associated diarrhea

RelatedReports

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer
StudyGraphics

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

January 24, 2023
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Chronic Disease

Early-life body size not an independent risk factor for colorectal cancer

January 11, 2023
Similar outcomes after supracervical vs. total hysterectomy
Oncology

Characterization of prognostic markers of residual neoplastic disease following hysterectomy

January 4, 2023
Stochastic resonance stimulation may decrease apnea of prematurity
Weekly Rewinds

2 Minute Medicine Rewind January 2, 2023

January 3, 2023
Next Post
Probiotic formulations do not prevent antibiotic-associated diarrhea

Probiotic formulations do not prevent antibiotic-associated diarrhea

A new biomarker for therapy-resistant graft-versus-host disease and death

A new biomarker for therapy-resistant graft-versus-host disease and death

Outreach increases colorectal cancer screening among underserved

Outreach increases colorectal cancer screening among underserved

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options